Page last updated: 2024-08-24

lamivudine and Esophageal Varices

lamivudine has been researched along with Esophageal Varices in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahn, SH; Bae, SH; Cheong, JY; Han, KH; Jang, BK; Jeong, SW; Kim, BI; Kim, DJ; Kim, JK; Kim, MY; Kim, SG; Kim, TY; Kwon, JH; Kwon, SY; Lee, HW; Lee, JW; Myoung, S; Park, JY; Seo, YS; Tak, WY; Yim, HJ; Yoon, KT1
Casazza, G; Colombo, M; de Franchis, R; Facchetti, F; Fraquelli, M; Iavarone, M; Invernizzi, F; Jovani, M; Lampertico, P; Loglio, A; Mangia, G; Primignani, M; ViganĂ², M1

Trials

1 trial(s) available for lamivudine and Esophageal Varices

ArticleYear
Long-term Outcomes of Antiviral Therapy in Patients With Advanced Chronic HBV Infection.
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2019, Volume: 17, Issue:13

    Topics: Antiviral Agents; Carcinoma, Hepatocellular; Esophageal and Gastric Varices; Female; Guanine; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Splenomegaly; Thrombocytopenia; Viral Load

2019

Other Studies

1 other study(ies) available for lamivudine and Esophageal Varices

ArticleYear
The long-term benefits of nucleos(t)ide analogs in compensated HBV cirrhotic patients with no or small esophageal varices: A 12-year prospective cohort study.
    Journal of hepatology, 2015, Volume: 63, Issue:5

    Topics: Adenine; Adult; Aged; Antiviral Agents; DNA, Viral; Dose-Response Relationship, Drug; Elasticity Imaging Techniques; Endoscopy, Gastrointestinal; Esophageal and Gastric Varices; Female; Follow-Up Studies; Forecasting; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunosuppressive Agents; Italy; Lamivudine; Liver; Liver Cirrhosis; Male; Middle Aged; Nucleosides; Organophosphonates; Prospective Studies; Reverse Transcriptase Inhibitors; Survival Rate; Tenofovir

2015